<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37180112</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Commentary: T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1164761</StartPage><MedlinePgn>1164761</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1164761</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1164761</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jiamei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaogu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Front Immunol. 2020 May 22;11:1027</RefSource><PMID Version="1">32528480</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="Y">T-Lymphocytes, Regulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T helper 17 cells</Keyword><Keyword MajorTopicYN="N">cell metabolism</Keyword><Keyword MajorTopicYN="N">fatty acid oxidation</Keyword><Keyword MajorTopicYN="N">regulatory T cells</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>12</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37180112</ArticleId><ArticleId IdType="pmc">PMC10167841</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1164761</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shan J, Jin H, Xu Y. T Cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus. Front Immunol (2020) 11:1027. doi:&#xa0;10.3389/fimmu.2020.01027</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01027</ArticleId><ArticleId IdType="pmc">PMC7257669</ArticleId><ArticleId IdType="pubmed">32528480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O, et al. . Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest (2015) 125:194&#x2013;207. doi:&#xa0;10.1172/JCI76012</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI76012</ArticleId><ArticleId IdType="pmc">PMC4382238</ArticleId><ArticleId IdType="pubmed">25437876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualdoni GA, KA M, G&#xf6;schl L, Boucheron N, Ellmeier W, Zlabinger GJ. The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation. FASEB J (2016) 30:3800&#x2013;9. doi:&#xa0;10.1096/fj.201600522R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600522R</ArticleId><ArticleId IdType="pubmed">27492924</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Gang X, Yang S, Cui M, Sun L, Li Z, et al. . The alterations in and the role of the Th17/Treg balance in metabolic diseases. Front Immunol (2021) 12:678355. doi:&#xa0;10.3389/fimmu.2021.678355</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.678355</ArticleId><ArticleId IdType="pmc">PMC8311559</ArticleId><ArticleId IdType="pubmed">34322117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluxton D, Petrasca A, Moran B, Fletcher JM. Differential regulation of human treg and Th17 cells by fatty acid synthesis and glycolysis. Front Immunol (2019) 10:115. doi:&#xa0;10.3389/fimmu.2019.00115</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00115</ArticleId><ArticleId IdType="pmc">PMC6369198</ArticleId><ArticleId IdType="pubmed">30778354</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Chi H. Metabolic control of treg cell stability, plasticity, and tissue-specific heterogeneity. Front Immunol (2019) 10:2716. doi:&#xa0;10.3389/fimmu.2019.02716</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02716</ArticleId><ArticleId IdType="pmc">PMC6917616</ArticleId><ArticleId IdType="pubmed">31921097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Huang L, Liu Y, Yi M, Chu Q, Jiao D, et al. . Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J Hematol Oncol (2022) 15(1):104. doi:&#xa0;10.1186/s13045-022-01322-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-022-01322-3</ArticleId><ArticleId IdType="pmc">PMC9364625</ArticleId><ArticleId IdType="pubmed">35948909</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y, Zhang C, Yang L, Zeng X, Hu Y, Xue X, et al. . The activation of PPAR&#x3b3; enhances treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent n-glycan branching of T&#x3b2;RII/IL-2R&#x3b1;. Cell Commun Signal (2022) 20(1):48. doi:&#xa0;10.1186/s12964-022-00849-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-022-00849-9</ArticleId><ArticleId IdType="pmc">PMC8991706</ArticleId><ArticleId IdType="pubmed">35392915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>